Accu-Chek Guide and Accu-Chek Performa blood glucose meters 14 November 2019 Product defect correction – risk of delayed therapy due to potential battery issues Consumers and healthcare professionals are advised that Roche Diabetes Care Australia, in consultation with the Therapeutic Goods Administration (TGA), is undertaking a product defect correction for Accu-Chek Guide and Accu-Chek Performa blood glucose meters. Accu-Chek Guide and Accu-Chek Performa blood glucose meters are used by people with diabetes to monitor their blood glucose (also known as blood sugar) levels. These meters are supplied individually and also in a meter kit. Please visit www.accu-chek.com.au for more information. The TGA Safety Advisory can be found at: https://www.tga.gov.au/alert/accu-chek-guide-and-accu-chek-performa-blood-glucose-meters
Media releases 14 February 2025 Diabetes Australia thanks retiring Federal MPs for their dedication Diabetes Australia has this week extended its gratitude to retiring Federal MPs Graham Perrett and Rowan Ramsey for their tireless... Continue Reading
Media releases 13 February 2025 Diabetes Australia calls for election commitments to improve tech access Diabetes Australia representatives are in Federal Parliament this week calling on both sides of politics to commit to funding equitable... Continue Reading
News 4 February 2025 Urgent calls for diabetes funding in 2025-26 Federal Budget The Diabetes Alliance has called on the Federal Government to commit to, and fund, the recommendations of the Parliament Inquiry... Continue Reading